Relaxant effects of some benzothiazolinone derivatives on isolated rabbit corpus cavernosum

Urological Research

Volumn 29, Issue 3, 2001, Pages 182-185

  Yildirim, S ^a   Simsek, R ^a   Ayan, S ^b   Gokce G ^b   Sarioglu Y ^a   Safak, C ^a  

^a CUMHURIYET UNIVERSITY   (Turkey)

^b Dept of Urology ^*  (Turkey)

Author keywords

Benzothiazolinone; Corpus cavernosum; Erectile dysfunction; Smooth muscle relaxation

Indexed keywords

3 [4 (PIPERONYL)PIPERAZINO]METHYL 6 (2 FLUOROBENZOYL) 2 BENZOTHIAZOLINONE; 3 [4 (PIPERONYL)PIPERAZINO]METHYL 6 BENZOYL 2 BENZOTHIAZOLINONE; BENZOTHIAZOLINE DERIVATIVE; GLIBENCLAMIDE; INDOMETACIN; N(G) NITROARGININE METHYL ESTER; TETRYLAMMONIUM CHLORIDE; UNCLASSIFIED DRUG; VASOACTIVE AGENT; Y 16; Y 21;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORPUS CAVERNOSUM; ERECTILE DYSFUNCTION; MALE; MUSCLE CONTRACTION; NONHUMAN; PRIORITY JOURNAL; RABBIT; SMOOTH MUSCLE RELAXATION; TISSUE CULTURE;

ANIMALS; BENZOTHIAZOLES; MALE; MUSCLE RELAXATION; MUSCLE, SMOOTH; PARASYMPATHOLYTICS; PENIS; PIPERAZINES; POTASSIUM CHANNEL BLOCKERS; RABBITS; TETRAETHYLAMMONIUM; THIAZOLES;

EID: 0034943704     PISSN: 03005623     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002400100187     Document Type: Article

References (18)

1. Physiology of penile erection
2. Neurotransmission and the contraction and the relaxation of penile erectile tissues
3. Endothelium- derived nitric oxide and cyclooxygenase products moduate corpus cavernosum smooth muscle tone
4. Prostaglandin E1 in the therapy of erectile deficiency
5. Sildenafil: An orally active type 5 cyclic GMP-specific phosphodiesterse inhibitor for the treatment of penile erectile dysfunction
6. The penis as a vascular organ
7. Synthesis and calcium antagonistic activity of (+)-(R)- and (-)-(S)-3-acetyl-2-[5-methoxy-2-[4-[N-methyl-N -(3,4,5-trimethoxyphenethyl)amino]butoxy]phenyl]benzothiazoline hydrochloride
8. Pharmacotherapy of erectile dysfunction
9. Physiology of erection and pharmacological management of impotence
10. Potential pharmacological value of acetylene compounds
11. A prospective double-blind trial of intracorporal papaverine versus prostaglandin E1 in the treatment of impotence
12. Effects of sildenafil on cAMP and cGMP levels in isolated human cavernous and cardiac tissue
13. Intracavernous pharmacotherapy
14. Intracavernous injection of papaverine for erectile failure
15. Auto-injection of the corpus cavernosum with a vasoactive drug combination for vasculogenic impotence